Supported through an unrestricted educational grant
from Novo Nordisk Pharmaceuticals, Inc.
 

Insulin Delivery Systems for the Management of Diabetes

Please read the following information and select the appropriate link at the bottom of the page to continue.

Release Date: May 2002
Expiration Date:
May 2004

Target Audience
This activity has been designed to meet the educational needs of pharmacists and registered nurses involved with the management of patients with diabetes.

Goal Statement
Provide pharmacists and nurses with information on the importance of glycemic control and knowledge of a variety of methods of insulin delivery so that they may guide patients with diabetes in selecting the most suitable delivery method.

Educational Objectives
Upon completion of this activity, participants should be able to:

  • Describe the importance of good glycemic control for patients with diabetes
  • Describe two insulin delivery systems currently in use in the United States, other than vial and syringe delivery
  • Compare vial and syringe delivery with insulin pens, other devices for insulin delivery, and continuous subcutaneous insulin infusion pumps
  • Outline the primary benefits and drawbacks of all delivery systems

  • Describe the characteristics that identify patients who might be good candidates for insulin delivery by various insulin delivery systems.

  • Describe potential benefits and drawbacks of implantable insulin pumps

  • List three future insulin delivery systems or routes of administration currently under study

CE Credit for successful completion of this independent study offering will be provided to pharmacists and nurses.

Editorial Review Board
Angela Bacque, RPh, MPA, CDE
Diabetes Self-Management Center
Rahway Hospital
Rahway, NJ

Lynne S. Weiss, RN, MS, CDE
Capital Health Systems
Trenton, NJ

Pharmacist Continuing Education
The Postgraduate Institute for Medicine and Novo Nordisk Pharmaceuticals, Inc. are approved by the American Council on Pharmaceutical Education as providers of continuing pharmaceutical education. The Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour (0.10 CEUs). Universal Program Number: 890-360/999-02-045-H01

A statement of credit will be issued only upon receipt of a successfully completed post-test (70% or better) and activity evaluation form.

Nursing Continuing Education
This educational activity for 1.2 contact hours is provided by Postgraduate Institute for Medicine. Postgraduate Institute for Medicine is approved as a provider of continuing education in nursing by the Colorado Nurses' Association, which is accredited as an approver of continuing education in nursing by the American Nurses Credentialing Center's Commission on Accreditation.

The Postgraduate Institute for Medicine is approved by the California Board of Registered Nursing, Provider Number 13485, for 1.2 contact hours.

Faculty Disclosure Statements
Postgraduate Institute for Medicine has a conflict of interest policy that requires course faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations/materials. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants.

Angela Bacque, RPh, MPA, CDE
, disclosed having no relationships with commercial entities related to the information presented in the publication.

Lynn S. Weiss, RN, MS, CDE
, disclosed having no relationships with commercial entities related to the information presented in the publication.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Postgraduate Institute for Medicine, Novo Nordisk Pharmaceuticals, Inc., and Pharmaceutical Information Associates do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Trademarks
NovoLog, Novolin, NovoPen3, NovoPen Junior, FlexPen, NovoPen 1.5, Innovo, PenFill, NovoFine, InnoLet, and Velosulin BR are registered trademarks of Novo Nordisk A/S.
Novolin Prefilled is a trademark of Novo Nordisk A/S.
InTouch is a registered trademark of LifeScan, Inc.
Humulin and Humalog are registered trademarks of Eli Lilly and Company.
Animas R1000 is a registered trademark of Animas Corporation.
H-TRONplus, Dahedi, D-TRON, and Disetronic Pen are trademarks of Disetronic Medical Systems, Inc.
Lantus is a registered trademark of Aventis Pharmaceuticals.
BD is a trademark of Becton Dickinson.
Autopen is a registered trademark of Owen Mumford, Ltd.
MiniMed 508 and Paradigm are registered trademarks of Medtronic MiniMed, Inc.
InDuo is a trademark of Johnson & Johnson and Novo Nordisk A/S.

Fee
There is no fee to receive credits for this continuing education activity.


Click the appropriate profession to continue to the activity:

Pharmacists click here

Nurses click here

Copyright ©2002 Novo Nordisk Pharmaceuticals, Inc. All rights reserved.

No part of this program may be reproduced, stored in a retrieval system, or transmitted in any form or by any means (electronic, electrostatic, magnetic tape, mechanical, photocopying, recording, or otherwise) without permission from Novo Nordisk Pharmaceuticals, Inc. Published by Health Answers Inc., 1140 Welsh Road, Suite 100, North Wales, PA 19454

HOME | HELP | EMAIL

NOTE: All of the tables and figures require Adobe Acrobat Reader

Click here to download Adobe Acrobat Reader for FREE

NOTE: All of the tables and figures require Adobe Acrobat Reader

Click here to download Adobe Acrobat Reader for FREE